chr5-35910500-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001042625.2(CAPSL):āc.181T>Gā(p.Phe61Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,612,362 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001042625.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CAPSL | NM_001042625.2 | c.181T>G | p.Phe61Val | missense_variant | 3/5 | ENST00000651391.1 | |
CAPSL | NM_144647.4 | c.181T>G | p.Phe61Val | missense_variant | 3/5 | ||
CAPSL | XM_006714444.4 | c.232T>G | p.Phe78Val | missense_variant | 3/5 | ||
CAPSL | XM_006714445.4 | c.232T>G | p.Phe78Val | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CAPSL | ENST00000651391.1 | c.181T>G | p.Phe61Val | missense_variant | 3/5 | NM_001042625.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250182Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135314
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460046Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726328
GnomAD4 genome AF: 0.000230 AC: 35AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2023 | The c.181T>G (p.F61V) alteration is located in exon 3 (coding exon 2) of the CAPSL gene. This alteration results from a T to G substitution at nucleotide position 181, causing the phenylalanine (F) at amino acid position 61 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at